Effectiveness of a domestic absorbable membrane with enhanced shielding function for tissue regeneration in defect areas: a multicenter, comparative, and controlled clinical trial

dentium0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年12月19日

适应症

试验速览

暂无简介。

•1) Patients over 20 years of age who has completed the skeletal growth
•2) Patients without disease or with a disease that is well controlled.
•3) Patients who have more than one tooth missing and need the bone graft procedure for implant restoration
•: Dentium implantation scheduled
•4) Patients who voluntarily decided to participate in this clinical trial and agreed to the consent form of the subject in writing.
•5) Patients who are willing to visit the clinic during a follow-up period and comply with a clinical trial plan

•1) Patients who are pregnant
•2) Patients who have metabolic diseases (uncontrolled diabetes, etc.)
•3) Patients taking drugs that can affect bone metabolism – bisphosphonates, rhPTH, denosumab, etc.
•4) Patients with uncontrolled gingivitis, periodontitis, or dental caries
•5) Patients who have received radiation therapy in the treatment area
•6) Patients with the hemorrhagic disease or need to take anticoagulants
•7) Patients allergic to bone graft/implant materials
•8) Smokers
•9) Other improper patients who are thought to be inappropriate for participation due to the ethical issue, or because it may affect the results of the clinical trial

发起方

dentium